The owl monkey (Aotus trivirgatus) has served as the standard non-human primate model of herpes simplex virus-1 (HSV-1) infection because it is highly susceptible to HSV-1 encephalitis. Owl monkeys, however, are expensive, difficult to obtain, and difficult to maintain in captivity, thus greatly hampering the efficiency of preclinical gene therapy trials for brain tumors using HSV-1-based vectors. We have therefore compared the susceptibility of the common marmoset (Callithrix jacchus) with the owl monkey in a model of intracerebral inoculation of wildtype HSV-1 F-strain at increasing titers. The common marmosets consistently succumbed earlier to viral encephalitis than the owl monkeys.
Introduction
Experimental non-human primate models are critical for evaluating the safety of promising viral vector constructs for potential clinical trials in humans. The owl monkey (Aotus trivirgatus) has served for a long time as the standard experimental model for preclinical safety testing of herpes simplex virus (HSV)-based viral vector systems in the brain. Reports of their high HSV susceptibility include earlier studies by Katzin et al, 1 who concluded that the pathology of the generalized infection closely resembles the picture seen in human newborn infants infected with HSV. In recent years, however, these New World primates have been increasingly difficult to obtain, thus jeopardizing the crucial preclinical-clinical transition of potentially promising novel antibrain tumor therapies.
The common marmoset (Callithrix jacchus), another yet smaller New World primate, has been shown to be susceptible to HSV infection [2] [3] [4] [5] and more recently, the marmoset has been proposed as experimental model for allergic encephalomyelitis, 6 for cytokine and gene therapy studies. [7] [8] [9] Common marmosets are bred in designated Primate Research Facilities within the United States and as such these animals are readily available at most biomedical research centers, thus facilitating experimental planning and potentially accelerating transitions into important clinical trials.
In order to determine the HSV-susceptibility of the common marmoset systematically and to carefully evaluate its usefulness versus the standard experimental model for gene therapy studies in the brain, we injected increasing titers of HSV-1 F-strain into the cerebrum of 10 common marmosets and six owl monkeys. To our knowledge such an extensive comparative susceptibility study has not been done before. Comparing the primary end points of outcome, histopathology and extra-CNS shedding route we conclude that the common marmoset is highly susceptible to intracerebral HSV-1 infection and that it can substitute for the owl monkey as a model for preclinical toxicity testing of promising vector constructs.
Results
Neurological outcome and survival Owl monkeys. As listed in Table 1a, animal 163-00 showed no clinical signs and was sacrificed healthy after 29 days in order to determine the cause of survival since animals with lower titers had succumbed to the infection at much earlier time points. Although 14 days postinoculation animal 167-00 (5 Â 10 3 plaque forming units (PFU)/ml) developed HSV-suspicious ulcerations on eyebrow, scrotum, and tail, swab tests taken from these lesions could not confirm dissemination of herpes simplex virus. Since this animal did not show any other clinical signs, it was kept alive and sacrificed on day 90. Animal 168-00 showed signs of decreasing activity and skin ulceration 7 days post-inoculation of 10 4 PFU/ml. Owl monkeys 162-00, 164-00, and 168-00 developed persistent neurological deficits including hind limb weakness, lethargy, and loss of body weight and on average had to be sacrificed due to these deficits on day 10, thereby defining the survival time for the control animal (161-00; sacrificed healthy), which received 10 ml of mock solution. , and 10 5 PFU/ml were found with seizures at day 5, 7 and 6, respectively, which led to sacrificing. Animal 180-97 of the first column (Table 1b) and animal 152-98 of the second column (Table 1c) were found dead  on day 5 and 6, having received 10 ml of 10  5 and  10 6 PFU/ml, respectively. The two control experiments were performed with survival times of 14 days and six days (both sacrificed healthy), which in the latter case equals the average survival time of the animals succumbing to the infection. Finally, only one of the animals injected with 5 Â 10 3 PFU/ml survived 90 days without clinical symptoms (3-98; sacrificed healthy), whereas the other one had to be sacrificed on day 6 due to persistent neurological deficit .
Pathology
Macroscopic examination of all brain, liver, and kidney specimens was unremarkable. Most of the brains had a punctate, superficial hemorrhagic area, measuring less than 1 mm, in the right parietal area, corresponding with the injection site. No large hemorrhages, infarcts, or hydrocephalic changes were noted.
Microscopic examination of the brain ( Figures 1  and 4 ) showed similar histological features although, as described below and in Table 2a -c, these varied markedly in severity and location between animals. Meningitis, when present, was mild, and characterized by lymphocytic infiltrates that were more prominent near regions of frank encephalitis. Encephalitis, when present, was cytologically highly similar to that seen in human HSV encephalitis. The cerebral parenchyma was infiltrated by both acute and chronic inflammatory cellswith neutrophils and lymphocytes, respectively -and marked microglial activation, including scattered microglial nodules. When copious acute inflammation was present, there was often accompanying acute hemorrhage and small infarcts of the involved tissue. Most cases with overt histological features of encephalitis had obvious eosinophilic nuclear inclusions, with some having classic Cowdry type A inclusions. Immunohisto- Owl monkeys. With rare exceptions, the owl monkeys developed a form of meningoencephalitis that closely recapitulated classical human herpes meningoencephalitis ( Figure 1 and Table 2a ). Inflammatory changes were Figure 1 Brain. Owl monkey (162-00; 10 6 PFU/ml). H&E (left) and Immunohistochemistry (right). Necrosis, hemorrhage and acute inflammation is noted in the hippocampus H&E (top, left). At higher power (H&E; bottom, left), neutrophils have infiltrated the cerebral parenchyma, surrounding neurons containing eosinophilic nuclei. Immunohistochemistry demonstrates extensive HSV capsid staining of neurons, particularly in the dentate gyrus of the hippocampus (top, right; low power). Note the numerous neutrophils seen at high power on the immunohistochemistry (bottom, right). Development of a non-human primate model TS Deisboeck et al widespread in the brain but were most severe in the cerebral hemispheres. This histological picture included both acute and chronic cerebral inflammation with numerous microglia, as well as Cowdry type A nuclear inclusions and immunohistochemical positivity for HSV capsid antigen in neuronal nuclei. A few areas, such as medial temporal lobe in one case, progressed to hemorrhagic infarction, again strikingly similar to the appearance of HSV encephalitis in humans. The histology of the scrotum skin lesions of animal 168-00 (10 4 PFU/ml HSV-1 F-strain) revealed herpetic dermatitis with herpes typical inclusion bodies. Other than that, only in animal 162-00, i.c. injected with 10 6 PFU/ml HSV-1 F-strain, shedding of the virus to other extra CNS organs could be documented with histopathology. The kidney of this animal shows signs of necrosis and inflammation ( Figure  2 , left). The immunohistochemistry for herpes simplex capsid antigen demonstrates multiple positive intranuclear inclusions (Figure 2 , right). In the liver of the same animal, multiple hepatocytes at the margins of a focus of necrosis contain intranuclear inclusions, again indicating HSV shedding ( Figure 3 ). None of the other animals, owl monkeys or common marmosets showed any specific histology findings related to or suspicious of HSV in kidney or liver.
Common marmosets. The marmoset brains had a somewhat different histological appearance (Table 2b and c). Most of these brains demonstrated extremely widespread HSV infection of neurons, as evidenced by innumerable immunopositive neurons in many different regions of the brain. However, inflammation was minimal relative to the degree of HSV infection, with many regions of cortex that were widely infected essentially lacking an inflammatory response ( Figure 4 ). The exception to this was the brain stem, which was markedly inflamed in some of the common marmosets, with acute and chronic inflammation, microglia, and Cowdry type A inclusions. It is noteworthy that animal 7-98, injected with only 5 Â 10 3 PFU/ ml HSV-1 F-strain showed a similar histological picture as the animals injected with higher titers, that is, 10 4 and 10 5 PFU/ml. This is distinctively different from the findings within the owl monkey group (compare with Table 2a ).
Herpes virus PCR Owl monkeys. After inoculation of the HSV-1 F-strain the serum PCR was positive in all animals, except the control animal, which received the mock solution (Table  3a) . It is noteworthy that in both, animal 163-00, which received 10 6 PFU/ml HSV-1 F strain, and animal 167-00, which was inoculated with only 5 Â 10 3 PFU/ml, the initially positive PCR turned negative 3-4 weeks postinoculation and remained negative until being sacrificed. Another striking finding is the negative PCR of brain 
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TS Deisboeck et al tissue in all but one animal (162-00) injected with HSV-1. This animal, which was inoculated with 10 6 PFU/ml HSV-1 F-strain is also the only one showing PCR positivity in all three tissue-types, that is, brain, liver, and kidney, which correlates well with the aforementioned histopathological findings. Generally, the PCR for liver and kidney was heterogeneous as it failed to show a clear pattern. 
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Common marmosets. In the first column (Table 3b) , only the serum of animal 7-98 failed to show PCR positivity after receiving 5 Â 10 3 PFU/ml HSV-1 F-strain (no post-injection specimen was available from animal 63-96 and for animal 152-98 (second column)). This finding was confirmed in the second column with animal 3-98, injected with the exact same titer (Table 3c ). Other than in the owl monkey group, the brain tissue PCR of the common marmosets showed positivity in five out of eight animals (62.5%) injected with the virus. Similar to the owl monkeys, the kidney appears to be also in the common marmoset the more sensitive organ for extra-CNS shedding of HSV-1. Both 5 Â 10 3 PFU/ml animals remained PCR negative for liver and kidney specimen; no kidney specimen was available from animal 63-96. As expected, the control animals were PCR negative for serum and tissue, respectively.
Discussion
The owl monkey is the classic experimental model for preclinical safety testing of HSV-based vector systems due to its well-documented high susceptibility to HSV infection. In recent years, however, these animals have become increasingly difficult to obtain, thus jeopardizing the transition of potentially promising novel brain tumor therapies into clinical trials in humans. We therefore sought to determine if the common marmoset could be used as a preclinical model instead. In their landmark studies, Hunt and Melendez stated that common marmosets are susceptible to HSV infection and that the syndromes are clinically and pathologically identical to HSV infections in owl monkeys.
2,3 Similarly, Meignier described not only that the marmoset succumbed to an intravaginal infection with (10 4 PFU) HSV-2 within 1 week, but that the survival results of the therapeutic vector constructs, designed on an HSV-1 F-strain backbone were in fact similar to the ones obtained with owl monkeys. 8 Although the virus in these studies has not been injected intracerebrally, these findings nonetheless already indicated the potential usefulness of the common marmoset for gene therapy studies -as an alternative for the owl monkey.
In our study, as expected, the owl monkeys were susceptible to HSV infection, showing severe symptoms approximately 10 days after injection and developing a form of meningoencephalitis that was histologically similar to classical human herpes meningoencephalitis, including Cowdry type A inclusions, acute inflammation as well as microglia, and hemorrhagic infarction in a few cases. These histological results are in accordance with results reported in the literature. 1, 10 Klatzin et al 1 describe a survival of only 6 days after ocular inoculation of the virus, which is similar to the 5 days reported by Hunter et al, who injected 10 3 PFU HSV-1 F-strain in the brain of their control animal. 11 Regardless of the fact that the survival times in our study were longer, that is, on average 10 days, the similarity in the histological findings indicates that the longer survival had little impact on the histological picture. Determined by the onset of severe symptoms, the survival time in our study is, however, comparable to the 6-8 days reported by Melendez et al 10 The common marmosets succumbed much sooner than the owl monkey, showing severe symptoms usually around 6 days post-injection, and their brains also displayed marked infection with HSV, with far more extensive HSV immunopositivity than seen in the owl monkeys. This survival time corresponds with the findings of Cho et al, 4 who reported an average survival time of 8 days after injecting 10 5 PFU HSV-1 intracerebrally into two marmosets. In our study, the marmoset brains showed substantially less inflammation in the cerebral hemispheres, but had classical histological findings of encephalitis in the brain stem, including acute and chronic inflammation, microglia, and Cowdry type A inclusions. One possible explanation for the relatively minor inflammatory reaction seen in the marmosets is the sudden onset of symptoms (ie, seizures) and, in two cases, death of the animals at an early time-point. The relatively quick demise may in fact not allow for the development of an extensive inflammatory picture similar to the one seen in the owl monkeys, which tend to survive on average four more days.
Juan-Salles et al not only found similar histological results investigating spontaneous HSV infections in four common marmosets, but also described already the usefulness of PCR in determining the extent of HSV infection. 14 The PCR results of our study not only support their assessment, but also clearly demonstrate a similar shedding route in both non-human primate models. It is noteworthy, that the kidney appears to be a more sensitive organ than the liver for extra CNS shedding of HSV-1 F-strain in both species. This finding is in accordance with reports from Cho et al, who were unable to isolate the virus in liver tissue of either one of two of their marmosets, which succumbed to the intracerebral infection with 10 5 PFU HSV-1 on day 6 and 10, respectively. 4 A striking finding is that the PCR of the brain tissue in the common marmoset was predominantly positive whereas only one out of five owl monkeys showed a positive brain tissue PCR, corresponding to the impressive histopathological findings in these animals. Another intriguing finding in the owl monkey group was the loss of the viral DNA in the serum in two out of five animals (40%) receiving distinctively different HSV-1 F-strain titers (5 Â 10 3 and 10 6 PFU/ml, respectively). The underlying physiological mechanism for this effect is not entirely clear, yet the fact that both animals were ELISA-negative at the beginning of the study and that this mechanism appeared to require at least 3 weeks post-inoculation to become (and remain) effective, suggests an acquired, antiviral immune response in both animals. This notion is supported by the findings of Todo et al, who injected 3 Â 10 7 PFU of the conditionally replicating HSV-1 mutant G207 into the brains of four Aotus nancymae. 15 These authors reported an increase of serum anti-HSV antibody titer as early as 21 days post-inoculation, measured by ELISA. It is therefore important to note that in our study none of the marmosets (column 1 or 2) showed a similar antiviral reaction. Finally, both common marmosets receiving 5 Â 10 3 PFU/ml HSV-1 F-strain showed positive brain PCR results regardless of their distinctively different survival times, yet had negative serum and extra-CNS Development of a non-human primate model TS Deisboeck et al tissue PCR findings. This indicates both, a high susceptibility of the marmoset brain as well as the absence of detectable extra-CNS viral shedding at this low titer. Specifically, the one animal succumbing to the disease after 6 days showed a marked meningoencephalitis, comparable to the histological picture seen at higher titers. Conversely, the owl monkey injected with the same low viral titer survived for 90 days without any clinical signs, showed only focal mild inflammation and negative brain PCR, aside from the aforementioned antiviral effect seen in the serum PCR.
Comparing the results of the histological evaluation with the PCR testing, we have found that, for example, in owl monkey 162-00 all three organ specimens histologically stained positive for HSV-1, which could be confirmed by PCR. The only common marmoset with a similar PCR pattern was animal 152-98, also having received the same viral titer of 10 6 PFU/ml. There are several possible explanations for the in some instances, differing results, regarding histopathology and PCR of the paraffinized tissue sections. (a) Depending on the storage time of the specimen, degradation of viral DNA in the paraffin-embedded tissue can occur and many DNA strand breaks could prevent PCR from detecting the virus. (b) Moreover, as histology is considered to be the 'gold standard', preference was given to this evaluation method for brain tissue sections obtained close to the injection site. It is thus conceivable that the slices used for the PCR were more distant to the area of infection, rendering a negative PCR result whereas the histological staining would be positive. (c) Thirdly, histology is proof of a manifest infection with viable herpes viruses whereas the PCR shows the presence of 'naked' DNA only and as such, viral DNA can be found in organs without histologically detectable reactive changes. This, however, means that the PCR, even though it has higher sensitivity to detect extra-CNS shedding of viral DNA, could be less reliable in detecting the clinical manifest infection. As such, both viral DNA shedding and HSV histology have distinct value and should be interpreted together.
In summary, we have evaluated the HSV-susceptibility of the common marmoset versus the owl monkey in a model of stereotactic, intracerebral inoculation of HSV-1 F-strain at increasing titers. Our findings clearly demonstrate that the common marmoset is at least as clinically susceptible to HSV-infection as the owl monkey, showing histological changes consistent with active infection as well as similar extra-CNS shedding routes. Given the necessity of determining the safety of any viral vector system for the use in humans, we conclude that the common marmoset (Callithrix jacchus) is a valid experimental model for preclinical toxicity testing of HSVbased vector constructs, and thus presents a valuable alternative to the owl monkey.
Materials and methods

Virus
Strain F of Herpes simplex virus (HSV) type 1 was chosen as it is the backbone of a number of therapeutic vector constructs, which are currently in clinical trials or under development.
11 HSV-1 F-strain was grown in African green monkey kidney (Vero) cells. To 90-100% confluent Vero cells, wildtype HSV-1 virus was added at a multiplicity of infection (MOI) of 1-3 and incubated in Dulbecco's minimal essential medium supplemented with 100 U of penicillin and 0.1 mg of streptomycin per ml of medium (GIBCO Invitrogen, Carlsbad, CA, USA). The cells were incubated in 371C and 5% CO 2 for 1-3 h. After initial infection the cell medium was supplemented with 10% fetal calf serum (SIGMA, St Louis, MO, USA) and the infected cells were incubated for an additional 48 h. Virus was then isolated after three freeze-thaw cycles and centrifugation at 1800 r.p.m. for 6 min at 41C. The virus was concentrated thereafter by high-speed centrifugation at 12 500 r.p.m. for 60 min at 41C. The titer of viral stocks was determined by a plaque assay on Vero cells. Viral stocks were maintained at À801C. Following each surgery, two 10 ml aliquots of the inoculum were stored at À801C to be able to confirm the titer by plaque assay.
Animals and procedures
All animal procedures were approved by the Standing Committee on Animals of Harvard Medical School (HMS) and performed according to the National Research Council (NRC) Guide for the Care and Use of Laboratory Animals (1996) . This study included: 16 New World primates, that is, 10 common marmosets (Callithrix jacchus; average body weight: (b.w.) 365 g; five males and five females) bred and housed at the New England Regional Primate Research Center (NERPRC, Harvard University) and six owl monkeys (Aotus trivirgatus; average b.w.: 876 g; six males) purchased through the National Institutes of Health (Bethesda, MD, USA) and housed separately at the NERPRC. Prior to injection, all animals were tested for tuberculin and quarantine blood samples were used for an enzymelinked immunosorbent assay (ELISA) to exclude animals with potential HSV-immunity. None of the animals, owls or marmosets, had a positive anti-HSV titer prior to the experiment. The animals from both species received 10 ml of one of the following viral titers: 5 Â 10 , and 10 4 PFU, respectively. We compared the results of the owl monkey column with two columns of the common marmosets, to determine the level of reproducibility of the findings in the marmoset model. Intracerebral injections of 'mock solution' (ie, 10 ml conditioned medium taken from Vero cell cultures without viral particles) served as control in one owl monkey and two common marmosets, respectively.
The animals were anesthesized with ketamine (7 mg/ kg i.m.), followed by isoflurane (1-2% with 3-4 l of oxygen (in case of pain indicated by increased heart rate during the operation, buprenorphine (0.005 mg/kg) was administered i.m.)). After induction of anesthesia and intubation the animal's head was positioned in a stereotactic frame (David Kopf Instruments, Tujunga, CA, USA), prepped with betadine soap and shaved. A 3.0 cm long scalp incision was performed starting 1.5 cm posterior of the eyebrow. After obtaining hemostasis, a small burr hole was placed 2 mm lateral right to the sagittal suture (under continuous cooling with physiologic sterile saline) and 8 mm posterior to the bregma, followed by an opening of the dura mater after careful Development of a non-human primate model TS Deisboeck et al cross-shaped coagulation. Using a stereotactic Kopf injection apparatus, a 26 gauge needle attached to a 25 ml Hamilton syringe (previously loaded with 10 ml of the HSV-1 F-strain solution) was slowly inserted 8 mm deep from the dura into the right brain hemisphere. To allow for slow diffusion of the virus into the brain parenchyma as well as to minimize reflux along the needle track, the 10 ml viral solution were injected in 20-s steps over 5 min and the removal of the needle followed over another 5 min. Afterwards, the burr hole was sealed with bone wax to prevent CSF leakage and the scalp incision was closed using 3-0 silk sutures. Finally, a layer of antibiotic cream was administered onto the stitches and the animal was taken out of the stereotactic frame for recovery.
Immediately after extubation, a neurological evaluation was made by the surgeons and the NERPRC staff to rule out neurological deficits caused by the surgical procedure. No motor deficit was noted for any of the animals immediately post-surgery. The animals were separately housed at the NERPRC before and after the inoculation as required by HMS biosafety level requirements. General health status (food uptake, level of activity, body weight) and changes in the neurological status (limb weaknesses, seizures) as well as visible signs of viral shedding (eg, skin ulceration) were assessed and recorded daily by qualified NERPRC staff. Temperature measurements and serum sampling was performed on a weekly basis only as the animals needed to be anesthesized for these procedures. The animals in both groups were euthanized as soon as uncontrollable symptoms occurred indicating severe disease (seizures, general weakness, lethargy, weight loss 420%, uncontrollable fever and infections) by administering sodium pentobarbitol (50 mg/kg, i.v.) to effect. Two common marmosets (180-97; 152-98) succumbed to the disease overnight. The time of euthanasia in the control animals (receiving mock solution) was determined by the average survival time of the animals receiving the HSV-1 F-strain (ie, 6 days for the common marmosets and 10 days for the owl monkey) to be able to evaluate the histological findings versus control. Euthanasia after 3 months in the common marmoset (3-98) and owl monkey (167-00), which each received 5 Â 10 3 PFU/ml and had both survived the initial phase, was chosen in order to be able to (a) assess long-term histological changes, yet (b) still allowing for identification of the injection site.
Pathology
After fixation in buffered formalin, all brains were examined macroscopically. Cerebral hemispheres were cut in the coronal plane and the brain stem in a horizontal plane, and were processed and embedded in paraffin. Liver and kidney specimens were also fixed in formalin, sectioned, processed and embedded in paraffin. Sections of brain, liver, and kidney were stained with hematoxylin and eosin as well as immunohistochemically with antibodies to HSV capsid antigen (Fitzgerald Industries International, Concord, MA, USA). After microwaving for 15 min in citrate buffer and blocking with normal horse serum, the sections were incubated overnight at 41C with the primary antibody (1:75 in PBS/ 1% bovine serum albumin). Following a secondary biotinylated horse anti-mouse antibody, the antibody was detected using a standard avidin-biotin complex method, with diaminobenzidine as the chromogen and a hematoxylin counterstain.
Herpes virus PCR
In order to determine the extent of viral shedding, a nested polymerase chain reaction (PCR) was performed, targeting the ICP6 gene locus of the herpes simplex virus with the following primer pairs: outer sense: GAGGAC GACTTTGGGCTTCT, outer antisense: GTGTGCGGT GTGCTGTGGAT, resulting in a 359 bp product. The inner PCR used the following primers: inner sense: TGGAGATGCAGCGCCTGTGT, inner antisense: TCCA GAGCCTGGGCCAGGAT, giving rise to a 288 bp sequence. The outer PCR employed 5 ml of template in a 30 ml reaction volume with 1.67 mM MgCl 2 , PCR-buffer without Mg (Gibco BRL, Grand Island, NY, USA), dNTP's 0.2 mM each, primer 0.2 mM, 2.5 U Taq polymerase (Gibco BRL) and Q-solution (Qiagen, Valencia, CA, USA). The following cycling pattern was used: 941C 2 0 , 571C 1 0 , 721C 2 0 , then 35 cycles of 941C 1 0 , 571C 1 0 , and 721C 1 0 followed by a 5 0 incubation at 721C. The inner PCR was set with the same concentrations of reagents but without Q-solution and using only 1 ml of the outer PCR product as template. The cycling pattern was: 941C 2 0 , 591C 1 0 , 721C 2 0 , 30 cycles of 941C 1 0 , 591C 1 0 ; and 721C 40 00 followed by an incubation at 721C for 5 0 . To assess the sensitivity of the PCR we performed several experiments. In a serial dilution of HSV DNA in H 2 O the detection limit of the PCR was determined to be below 200 copies per 5 ml. A virus preparation with a known number of PFU was heat denaturated in TE-buffer and HSV DNA could be detected in a concentration of five virions per 5 ml. We also specifically tested three of the inoculation solutions used for injection into monkey brains. They had a concentration of 5 Â 10 3 virions per milliliter; since all three PCRs were positive, the detection limit was calculated to be less then 25 virions/5 ml. For the examination of animal specimens, serum DNA was extracted with the viral RNA kit (Qiagen) according to the instructions of the manufacturer. This kit employs carrier RNA to help purify small RNA or DNA amounts from cell-free liquids. Puregene (Gentra, Minneapolis, MN, USA) was used for DNA purification from paraffin-embedded tissues. We investigated brain tissue, and in order to evaluate visceral shedding, also evaluated liver and kidney specimens. Four slices of 14 mm thickness were cut immediately prior to the extraction. The tissue was freed of paraffin boundaries and then deparaffinized in three washes of xylene and two washes of ethanol. According to the instructions of the manufacturer the tissues were digested overnight in the presence of proteinase K. Proteins were precipitated on ice and DNA extracted from the supernatant using isopropanol/glycogen precipitation. Finally, DNA was redissolved in 20 ml of TEbuffer.
